Tysabri: Solution for injection (300mg)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
What is this Medicine?
NATALIZUMAB (na ta LIZ you mab) is used to treat relapsing multiple sclerosis. This drug is not a cure. It is also used to treat Crohn's disease.
Tysabri 300mg/15ml Solution for Injection
NDC: 644060008-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Crohn's Disease, Multiple Sclerosis
Refrigerate (between 36 and 46 degrees F)
Protect from light
Store in carton until time of use
Protect from freezing
Diluted product must be used within 8 hours
Reported Side Effects for Tysabri 300mg/15ml Solution for Injection
Onset: RAPID
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: RAPID
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics